FDA: Global Pharma’s eye drops contaminated with 'filth' while Amazon made unapproved claims for eye drops
Regulatory NewsJoanne S. Eglovitch
Advertising, Promotion and LabelingComplianceOTCPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyUnited States